Endocrine Cancer
News
No survival benefit of RAI seen in early-stage thyroid cancer
Key clinical point: Radioactive iodine appears to offer the best survival impact in patients with advanced differentiated thyroid carcinoma. Major...
News
Anticoagulants sharply increase hematoma risk after thyroid, parathyroid surgery
Key clinical point: Clopidogrel and anticoagulants are risk factors for hematoma after thyroid or parathyroid surgery. Major finding: The odds of...
Conference Coverage
Tests pinpoint primary sources of neuroendocrine bowel, pancreatic metastases
Key clinical point: Gene expression can be used to identify the primary source of neuroendocrine small bowel and pancreatic metastases.Major...
News
Experimental lenvatinib extends PFS in iodine-refractory relapsed thyroid cancer
Key clinical finding: The investigational drug lenvatinib significantly prolonged progression-free survival and produced high response rates...
News
Pasireotide decreases incidence of postoperative fistula
Key clinical point: Pasireotide reduced the incidence of postoperative pancreatic fistula, leak, or abscess.Major finding: Compared with placebo,...
News
Lobectomy suffices for surgery of small papillary thyroid cancers
Major finding: After adjustment, total thyroidectomy did not improve overall survival over lobectomy for tumors 1-2 cm (HR, 1.05; P = .61) or 2.1-...
Conference Coverage
Growth hormone levels predict postsurgical acromegaly remission
Major finding: Acromegaly patients with preoperative GH levels greater than 40 ng/mL had a 15% remission rate at 3 months, compared with 58% in...
Conference Coverage
New chemo regimen is active against recalcitrant neuroendocrine tumors
Major finding: The overall response rate was 43% and the clinical benefit rate was 97%. Data source: A randomized phase II trial among 28 patients...
Conference Coverage
Prolactin measure didn’t help localize pituitary adenoma
Major finding: The unadjusted and prolactin-adjusted ACTH intersinus ratios correctly localized 18 of 26 lateral pituitary adenomas (69%),...
Conference Coverage
Pituitary tumor size not definitive for Cushing's
Major finding: A pituitary tumor larger than 6 mm on MRI was 40% sensitive and 96% specific for a diagnosis of Cushing’s disease as the cause of...
Conference Coverage
Stereotactic laser ablation found feasible for hypothalamic hamartoma
Major finding: After 20 patients with hypothalamic hamartoma underwent MR-guided stereotactic laser ablation, all but 4 were seizure free.Data...